AGM
HAE icon

Alpine Global Management’s Haemonetics HAE Stock Holding History

Alpine Global Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,922
Closed -$79K – 401
2015
Q2 		$79K Buy
+1,922
New +$81K 0.01% 644

Other funds holding HAE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Alpine Global Management's HAE Position: Q3 2015 in Review

Alpine Global Management sold out of Haemonetics (HAE) in Q3 2015, closing a stake of 1,922 shares — an estimated $79K sold.

Alpine Global Management first reported a position in HAE in Q2 2015 and held it in 1 quarter. The position peaked at $79K in Q2 2015. 172 funds tracked by Wall St. Rank hold HAE as of Q3 2015.

  • Alpine Global Management reported no remaining Haemonetics position as of Q3 2015 after selling out during the quarter.
  • Alpine Global Management sold 1,922 Haemonetics shares in Q3 2015, an estimated $79K.
  • Alpine Global Management first reported a position in Haemonetics in Q2 2015 and held it in 1 quarter.
  • Alpine Global Management's Haemonetics position peaked at $79K in Q2 2015.
  • 172 funds tracked by Wall St. Rank held Haemonetics as of Q3 2015.

Based on Alpine Global Management's 13F filing for Q3 2015, filed 10 Nov 2015.